Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Stacy A. Voils"'
Autor:
Catherine H. Vu, Veena Venugopalan, Barbara A. Santevecchi, Stacy A. Voils, Reuben Ramphal, Kartikeya Cherabuddi, Kathryn DeSear
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (ESBL-E BSIs). Design: Ret
Externí odkaz:
https://doaj.org/article/f4d80f16180d4a47afc0300300347221
Autor:
John M. Allen, Devi Surajbali, Dalena Q. Nguyen, Jolanta Kuczek, Maithi Tran, Brianna Hachey, Carinda Feild, Bethany R. Shoulders, Steven M. Smith, Stacy A. Voils
Publikováno v:
The Annals of pharmacotherapy.
Background: Sepsis and septic shock are associated with significant morbidity and mortality. Rapid initiation of appropriate antibiotic therapy is essential, as inadequate therapy early during septic shock has been shown to increase the risk of morta
Autor:
Stacy A. Voils, Laurence M. Solberg, Sonal Singh, Reginald F. Frye, Bethany R. Shoulders, Timothy J. Garrett
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 40:500-506
Introduction In intensive care unit (ICU) patients, delirium is frequent, occurs early in ICU admission, and is associated with poor outcomes. Risk models based on clinical factors have shown variable performance in terms of predictive ability. Ident
Publikováno v:
Am J Pharm Educ
Objective. To determine whether third year Doctor of Pharmacy students’ self-reported use of optional supplemental material impacted their ability to accurately predict their performance on a low-stakes assessment. Methods. An instructor created op
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(2)
Background Engraftment syndrome (ES) is a common complication of autologous hematopoietic cell transplantation (HCT). The difference in incidence of ES between melphalan formulations has not been widely reported throughout the literature and would al
Autor:
Bethany R, Shoulders, Sarah, Elsabagh, Douglas J, Tam, Amanda M, Frantz, Kaitlin M, Alexander, Stacy A, Voils
Publikováno v:
The American Surgeon. :000313482110697
Background Delirium occurs frequently in critically ill and injured patients and is associated with significant morbidity and mortality. Limited data exists on the risk factors for developing delirium in critically ill trauma patients and the effect
Publikováno v:
Annals of Pharmacotherapy. 53:385-395
Objective: Describe recent developments in the pharmacological management of sepsis and septic shock, focusing on fluid resuscitation, vasopressors, and corticosteroids. Data Sources: A literature search limited to randomized controlled trials writte
Autor:
Kenneth P. Klinker, Stacy A. Voils, Veena Venugopalan, Samuel J. Borgert, Kairav Shah, Kartikeya Cherabuddi, Lacie McKamey
Publikováno v:
International Journal of Antimicrobial Agents. 52:719-723
Management of micro-organisms harbouring AmpC β-lactamases remains challenging. Carbapenems are often considered first-line agents. Due to growing concern regarding carbapenem-resistant Enterobacteriaceae, integrating non-carbapenem treatment strate
Publikováno v:
Thrombosis Research. 165:6-13
Incidence of venous thromboembolism (VTE) in critically ill patients remains unacceptably high despite widespread use of thromboprophylaxis. A systems biology approach may be useful in understanding disease pathology and predicting response to treatm
143. Modification of Linezolid Restriction Criteria Reduces ICU Gram-positive Antibiotic Consumption
Autor:
John M Boulos, Catherine H Vu, Megan Logan, Bethany R. Shoulders, Barbara A Santevecchi, Stacy A. Voils, Veena Venugopalan, Kathryn E. DeSear
Publikováno v:
Open Forum Infectious Diseases
Background Antibiotic time out (ATO) policies have been proposed by the Centers for Disease Control and Prevention to limit unnecessary use of antibiotics. Critically ill patients are often treated empirically with MRSA-active agents for a prolonged